Connection
Nicholas Foreman to Etoposide
This is a "connection" page, showing publications Nicholas Foreman has written about Etoposide.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.132 |
|
|
|
-
Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer. 2007 Apr; 48(4):403-7.
Score: 0.069
-
Madden JR, Fenton LZ, Weil M, Winston KR, Partington M, Foreman NK. Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma. Med Pediatr Oncol. 2001 Jul; 37(1):67-9.
Score: 0.046
-
Korones DN, Smith A, Foreman N, Bouffet E. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas. Pediatr Blood Cancer. 2006 Jul; 47(1):37-41.
Score: 0.016